Weekly Roundup: January 25, 2019

This week we are looking at the USFDA’s proposed plans to address the expected rise in cell and gene therapy product applications and a significant development in a new controversial procedure called gene drive.

Also, P4A is starting a new campaign that will run throughout February to mark Rare Disease Day. The ‘6P’ campaign is aimed at creating awareness on the impact of rare diseases on key stakeholders and the need for partnership to achieve successful treatment access for patients. The 6Ps are Partnership, Patient, Policy-maker, Physician, Pharma and Payer. P4A will roll out a series of podcast episodes featuring thought leaders representing these stakeholders. So make sure you listen in!

Presenter: Joanna Fernandes

Contributors: Nader Murad and Sophie Schmitz

Producer: Aparna Krishnan